Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers 2024-10-24 10:00
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation 2024-10-24 08:08
Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance 2024-10-23 21:00
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia 2024-10-23 20:00
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia 2024-10-23 15:11
Samsung Biologics reports third quarter 2024 financial results 2024-10-23 14:55
Australia's Healthcare Innovators in Stroke and Paediatric Care Honoured at 2024 Challenger Summit 2024-10-23 09:29
Bloomage 'YunZhong (In Cloud) Public Welfare' Campaign: A 14-Year Journey of Cultural Preservation and Sustainability 2024-10-22 21:00
Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals 2024-10-22 18:57
Minghui Pharmaceutical Inc. Announces Positive Topline Results from Phase Ib/II Clinical Trial of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Patients with Active, Moderate-to-Severe Thyroid Eye Disease (TED) 2024-10-22 18:00
HELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure 2024-10-22 13:47
【C.S】Cordyceps Sunshine Biotech Uplists to OTCQB, Aims for a Potential Nasdaq Uplisting 2024-10-22 06:00
Origin Agritech Establishes Biotechnology Service Consortium to Accelerate Licensing and Commercialization of GMO and Gene Editing Technologies 2024-10-21 19:30
NIANCE Unveils Groundbreaking White Paper on Beauty and Longevity: Addressing the 12 Hallmarks of Aging 2024-10-21 15:48
Great Bay Bio Intelligent Drug Development Ecosystem Officially Launched 2024-10-21 13:57
Chang Gung Memorial Hospital Unveils Cellular Therapy: A Beacon of Hope for Cancer Treatment 2024-10-21 09:03
MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum 2024-10-18 22:09
LaNova Medicines Announces Initiation of Phase 1 Clinical Trial of Anti-PD-1/VEGF Bispecific Antibody LM-299 and Completion of $42 Million Series C1 Financing 2024-10-18 18:00
City microbes surviving on disinfectants, research reveals 2024-10-18 17:24
111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 - Conference Call to Follow 2024-10-18 17:00
1 12 13 14 15 16 458